<DOC>
	<DOCNO>NCT00064792</DOCNO>
	<brief_summary>This study evaluate safety effectiveness simvastatin treat child Smith-Lemli-Opitz syndrome ( SLOS ) . Patients inherited disease deficient enzyme convert substance call 7-dehydrocholesterol ( 7-DHC ) cholesterol . Cholesterol synthesis impair , cause birth defect mental retardation . This study examine whether simvastatin increase amount deficient enzyme , thereby lower 7-DHC increase cholesterol . It examine safety simvastatin affect child effect behavioral problem . Children 4 18 year age mild typical SLOS may eligible study . Participants evaluate NIH Clinical Center Bethesda , MD , Kennedy Krieger Institute Baltimore , MD , upon admission study 6 , 12 , 20 , 26 month . The visit last 3 4 day , include medical history physical examination , photographs document medical finding , procedure detail . In addition , blood sample collect 1 , 3 , 9 , 14 , 15 , 17 , 23 month . Parents complete several questionnaire study . Procedures include follow : - Simvastatin cholesterol supplementation therapy . Patients take cholesterol supplement ( 50 milligram per kilogram per day ) plus simvastatin ( 0.5 mg/kg/day 6 week 1 mg/kg/day ) 12 month , cholesterol supplement plus placebo 12 month . - Blood draw check liver , muscle , kidney function , hormone level , vitamin D level , blood count , cholesterol 7-DHC level , lipoprotein level . Some extra blood draw research purpose . - Urine collection . Urine collect use toilet hat . For child toilet train , urine collect bag tap skin adhesive . - Electroretinogram ( ERG ) measure function retina , light-sensitive tissue back eye . ERG do sedation . After adapt child 's eye dark , electrode tap child 's forehead , surface one eye numb eye drop , contact lens place eye . The child look inside globe emits series light flash . The contact lens sense electrical signal generate retina light flash . After ERG , patient full eye exam , include pupil dilation photograph eye . - Lumbar puncture ( spinal tap ) collect sample cerebral spinal fluid ( CSF ) . This procedure , do patient sedate ERG , show whether simvastatin affect brain cholesterol chemical level . Under local anesthetic , needle inserted space bone low back CSF circulate spinal cord . A small amount fluid collect needle . - CRH stimulation test detect hormone-related problem cholesterol synthesis . The patient give CRH , hormone involve cholesterol synthesis , plastic tube place vein . Blood sample collect catheter measure level hormone involve cholesterol production . - Electroencephalogram ( EEG ) look electrical activity ( brain wave ) child 's brain . - Activity monitoring . An activity monitor , look like worn like watch , use record child 's level activity 48-hour period . - Urine pregnancy test every visit female patient age 10 . - Skin swab sterol ( solid alcohol , cholesterol ) analysis . An alcohol pad rub lightly child 's arm thigh collect skin cell . - Stool collection . A small stool sample collect child 's diaper , child toilet train , toilet `` hat '' like use collect urine .</brief_summary>
	<brief_title>Simvastatin Therapy Smith-Lemli-Opitz Syndrome</brief_title>
	<detailed_description>Smith-Lemli-Opitz syndrome ( SLOS , RSH , OMIM # 270400 ) autosomal recessive , multiple malformation , mental retardation syndrome due inborn error cholesterol biosynthesis . Specifically , patient deficiency 3 beta-hydroxysterol Delta 7-reductase activity due mutation 3 beta-hydroxysterol delta 7-reductase gene ( DHCR7 ) . This enzymatic deficiency impairs conversion 7-dehydrocholesterol ( 7-DHC ) cholesterol last step cholesterol biosynthesis via Kandutch-Russel biosynthetic pathway . The clinical manifestation SLOS extremely variable phenotypic spectrum broad . At severe end spectrum SLOS lethal disorder multiple major congenital anomaly , mild case SLOS combine minor physical stigma behavioral learn disability . Based clinical study , incidence SLOS order 1/10,000 1/60,000 . Molecular study show carrier frequency 1 % common SLOS mutant allele North American population . Currently therapy base dietary cholesterol supplementation . Although clinical improvement note , serum cholesterol level rarely normalize elevate serum 7-DHC level persist . Because elevated 7-DHC level may toxic effect , treatment SLOS patient HMG-CoA reductase inhibitor propose . Two small ( two-patient ) open trial simvastatin therapy SLOS report . One trial show improved clinical status , decrease 7-DHC level increase cholesterol level . The second trial show decreased 7-DHC level ; however , treatment discontinue one patient preexist liver disease . The goal clinical research protocol test clinical efficacy safety simvastatin therapy mild classical SLOS patient use double blind , crossover design .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cleft Palate</mesh_term>
	<mesh_term>Hypertelorism</mesh_term>
	<mesh_term>Hypospadias</mesh_term>
	<mesh_term>Genetic Diseases , X-Linked</mesh_term>
	<mesh_term>Smith-Lemli-Opitz Syndrome</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>INCLUSION CRITERIA : All patient biochemically proven SLOS consider study . EXCLUSION CRITERIA : Patients exclude travel NIH medical condition . Age less 4 old 18 . Weight le 10 kg . Developmental delay severe obtain adequate behavioral evaluation . Severe behavioral problem preclude proper physical laboratory medicine evaluation . SLOS severity score great 30 . No biochemical diagnosis SLOS . No molecular conformation SLOS . Residual fibroblast enzymatic activity le 10 % control value ( cholesterol synthesis fraction total sterol synthesis ) . Dehydrocholesterol/cholesterol ratio great 1.0 . Renal insufficiency . Contraindications simvastatin use : History hypersensitivity simvastatin `` statin . '' Acute liver disease . Persistent elevation serum transaminase level persistent elevation CPK . Concomitant therapy tetralolclass calcium channel blocker ( mibefradil ) . Pregnancy lactation . History rhabdomyolysis myopathy . Concomitant therapy drug associate myopathy ( gemfibrozil fibrates , niacin ) metabolism P450 isoform 3A4 system ( cyclosporin , itraconazole , ketoconazole , macrolide antibiotic , nefazodone ( Serzone ) ) . Warfarintype anticoagulant therapy . Severe cataract .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Cholesterol</keyword>
	<keyword>SLOS</keyword>
	<keyword>HMG-COA Reductase Inhibitor</keyword>
	<keyword>Malformation Syndrome</keyword>
	<keyword>Mental Retardation</keyword>
	<keyword>Smith-Lemli-Opitz Syndrome</keyword>
</DOC>